Intensive Robotic Rehabilitation in Children With Hemiparesia Using GEOSYSTEM (RIPHIGEO)
Primary Purpose
Infantile Hemiplegia
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Intensive robotic rehabilitation
classical physiotherapy
Sponsored by
About this trial
This is an interventional treatment trial for Infantile Hemiplegia focused on measuring Infantile hemiplegia, Cerebral palsy, Intensive robotic rehabilitation
Eligibility Criteria
Inclusion Criteria:
- Hemiplegic children aged from 4 to 18 years
- GMFCS (Gross Motor Function Classification System) score between I and III with lower limb involvement.
- Children must walk alone with or without aid at least 10 meters, must have acquired sitting position, must be able to understand simple orders to follow the rehabilitation program.
- Free and informed consent of holders of parental authority and of the patient
- Affiliated to the social security system
Exclusion Criteria:
- No lower limb involvement,
- spasticity = 4 on the modified Ashworth scale,
- severe cardiorespiratory disease forbidding the rehabilitation program,
- orthopedic surgery or botulinic toxin injections in the last 6 months before the beginning of the study.
Sites / Locations
- CHU Clermont Ferrand
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Cohort 1 : experimental group
Cohort 2 : controle group
Arm Description
5 sessions per week of 30 minutes of robot-assisted rehabilitation with the G-EO system during two weeks
3 sessions per week of 30 minutes of classical physiotherapy during two weeks
Outcomes
Primary Outcome Measures
Gait speed
gait speed assessed during a gait assessment session using the GRAIL system
Gait speed
gait speed assessed during a gait assessment session using the GRAIL system
Gait speed
gait speed assessed during a gait assessment session using the GRAIL system
Secondary Outcome Measures
6 min. walk test (6-WT)
endurance evaluation by 6 min. walk test (6-WT)
6 min. walk test (6-WT)
endurance evaluation by 6 min. walk test (6-WT)
6 min. walk test (6-WT)
endurance evaluation by 6 min. walk test (6-WT)
joint angles
Joint amplitudes measured during gait assessment with the GRAIL
joint angles
Joint amplitudes measured during gait assessment with the GRAIL
joint angles
Joint amplitudes measured during gait assessment with the GRAIL
number of steps per 24h
Number of steps per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
number of steps per 24h
Number of steps per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
number of steps per 24h
Number of steps per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
travelled distance
distance traveled per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
travelled distance
distance traveled per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
travelled distance
distance traveled per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
quality of sleep: wristband actimeter
quality of sleep per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
quality of sleep: wristband actimeter
quality of sleep per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
quality of sleep: wristband actimeter
quality of sleep per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
cardiac frequency
heart rate per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
cardiac frequency
heart rate per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
cardiac frequency
heart rate per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Evaluation of spasticity
Evaluation of spasticity by the modified Ashworth scale
Evaluation of spasticity
Evaluation of spasticity by the modified Ashworth scale
Evaluation of spasticity
Evaluation of spasticity by the modified Ashworth scale
functional independence
Overall functional independence assessed with the MIF-Môme autonomy scale
functional independence
Overall functional independence assessed with the MIF-Môme autonomy scale
functional independence
Overall functional independence assessed with the MIF-Môme autonomy scale
motor functions
Overall motor function evaluated with the EMFG
motor functions
Overall motor function evaluated with the EMFG
motor functions
Overall motor function evaluated with the EMFG
muscular strength
Muscle strength will be measured with a quotation scale (1 to 5) for manual muscle testing
muscular strength
Muscle strength will be measured with a quotation scale (1 to 5) for manual muscle testing
muscular strength
Muscle strength will be measured with a quotation scale (1 to 5) for manual muscle testing
Body composition measurements
fat body mass
Body composition measurements
fat body mass
Body composition measurements
lean body mass
Body composition measurements
lean body mass
brain activated areas
Functional brain connectivity analyzes by functional brain MRI
brain activated areas
Functional brain connectivity analyzes by functional brain MRI
Full Information
NCT ID
NCT04246788
First Posted
January 24, 2020
Last Updated
January 10, 2022
Sponsor
University Hospital, Clermont-Ferrand
Collaborators
Université d'Auvergne
1. Study Identification
Unique Protocol Identification Number
NCT04246788
Brief Title
Intensive Robotic Rehabilitation in Children With Hemiparesia Using GEOSYSTEM
Acronym
RIPHIGEO
Official Title
Intensive Robotic Rehabilitation in Children With Hemiparesia Using GEOSYSTEM
Study Type
Interventional
2. Study Status
Record Verification Date
April 2021
Overall Recruitment Status
Completed
Study Start Date
July 17, 2020 (Actual)
Primary Completion Date
November 24, 2021 (Actual)
Study Completion Date
November 24, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Clermont-Ferrand
Collaborators
Université d'Auvergne
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Cerebral palsy is the most frequent motor deficiency in children. Among other, it can leads to spastic diplegia or hemiplegia. Walking abilities is an important skill to the families' point of view in term of independence in curent life. Improving the walking parameters has been the main objective in several studies of rehabilitation. The G-EO system is a last generation robot assisting gait training that can adjust cadence, walk lengh, ankle and hip angles and other walking parameters to movement captation. Its superiority in terms of walking abilities has been demonstrated in adults with stroke sequelae. Only one study was realized in pediatric patients with spastic diplegia with promising results. The investigators hypothesize that intensive robot-assited gait training using the G-EO system in hemiplegic children can improve their walking abilities.
Detailed Description
Objective :
Primary objective: To evaluate walking velocity with the GRAIL (gait real-time analysis and interactive lab) after intensive robot-assisted gait training using the G-EO system in hemiplegic children.
Secondary objectives :Other parameters that will be evaluate include:
Endurance on the 6 minute walking test
Joint angles and muscular contraction on the GRAIL
Number of steps and travelled distance /24h, cardiac frequency and quality of sleep using actimeter bracelet
Motor functions using the GMFM (Gross Motor Function Measure)
Spasticity using the modified Ashworth scale
The functional independence using the Functional Independence Measure (FIM™) for children,
The quality of life using the Patient Global Impression (PGI-I)
Muscular strength using the muscular testing cotation scale
The musculo-squeletal and adipose composition using the peripherical quantitative computed tomography (pQCT)
The cerebral area activation using functional MRI Study Type: Controlled randomized pilote study Number of centres: Monocentric study, University hospital of Clermont-Ferrand
Study procedure:
Experimental group: 5 sessions per week of 30 minutes of robot-assisted rehabilitation with the G-EO system during two weeks
Control group : 3 sessions per week of 30 minutes of classical physiotherapy during two weeks
Study evaluation:
T0 : before rehabilitation :
Actimeter for 24h
6 min walking test
GRAIL
Modified Ashworth scale
FIM for children
GMFM
Muscular testing scale
pQCT
fMRI
T1 : one month after rehabilitation :
idem T0
PGI-I questionnary Principal judgement criteria: Walking velocity Secondary judgement criteria: endurance, joint angles, number of steps and travelled distance per 24h, quality of sleep, cardiac frequency, spasticity, functional independence, motor functions, muscular strength, musculo-squeletal and adipose composition, brain activated areas.
Number of subjects:
20 patients in the experimental group
20 patients in the control group All patients enrolled in the control group will benefit of the GEOsystem rehabilitation at the end of the protocole
Inclusion criteria:
Hemiplegic children aged from 4 to 18 years, with a GMFCS (Gross Motor Function Classification System) score between I and III with lower limb involvement. Children must walk alone with or without aid at least 10 meters, must have acquired sitting position, must be able to understand simple orders to follow the rehabilitation program.
Non inclusion criteria:
No lower limb involvement, spasticity = 4 on the modified Ashworth scale, severe cardiorespiratory disease forbidding the rehabilitation program, orthopedic surgery or botulinic toxin injections in the last 6 months before the beginning of the study.
Study calendar:
Starting inclusions: March 2020
Experimental procedure: March 2020 to March 2021
Data analyses and synthesis: April 2021 to Dember 2021
Statistical analyses Statistical analysis will be performed using Stata 13 software (Stata-Corp, College Station, TX) by an experimented statistician (Bruno Pereira) working in the university hospital of Clermont-Ferrand. A type-I error set at α=0.05 will be considered. Monovariate and multivariate analyses considering age as a covariable will be performed.
Ethical considerations This study has already been presented at the local ethical committee and will be presented in July 2019 at the national " comité de protection des personnes ". Written informed consent from both parents will be collected at the inclusion. This study will be in agreement with the declaration of Helsinki and the current regulations of clinical trials. It will be declared on the internet site "clinicaltrials.gov".
Expected results :
Intensive robot-assisted gait training using the G-EO system may improve the walking abilities in children with infantile hemiplegia and consequently improve their independence and quality of life. Musculo-squeletal parameters and profile of cerebral activated areas involved in praxia may also be modified by this intensive rehabilitation.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infantile Hemiplegia
Keywords
Infantile hemiplegia, Cerebral palsy, Intensive robotic rehabilitation
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Cohort 1 : experimental group
Arm Type
Experimental
Arm Description
5 sessions per week of 30 minutes of robot-assisted rehabilitation with the G-EO system during two weeks
Arm Title
Cohort 2 : controle group
Arm Type
Active Comparator
Arm Description
3 sessions per week of 30 minutes of classical physiotherapy during two weeks
Intervention Type
Other
Intervention Name(s)
Intensive robotic rehabilitation
Intervention Description
5 sessions per week of 30 minutes of robot-assisted rehabilitation with the G-EO system during two weeks
Intervention Type
Other
Intervention Name(s)
classical physiotherapy
Intervention Description
3 sessions per week of 30 minutes of classical physiotherapy during two weeks
Primary Outcome Measure Information:
Title
Gait speed
Description
gait speed assessed during a gait assessment session using the GRAIL system
Time Frame
day 1
Title
Gait speed
Description
gait speed assessed during a gait assessment session using the GRAIL system
Time Frame
day 21
Title
Gait speed
Description
gait speed assessed during a gait assessment session using the GRAIL system
Time Frame
day 51
Secondary Outcome Measure Information:
Title
6 min. walk test (6-WT)
Description
endurance evaluation by 6 min. walk test (6-WT)
Time Frame
day 1
Title
6 min. walk test (6-WT)
Description
endurance evaluation by 6 min. walk test (6-WT)
Time Frame
day 21
Title
6 min. walk test (6-WT)
Description
endurance evaluation by 6 min. walk test (6-WT)
Time Frame
day 51
Title
joint angles
Description
Joint amplitudes measured during gait assessment with the GRAIL
Time Frame
day 1
Title
joint angles
Description
Joint amplitudes measured during gait assessment with the GRAIL
Time Frame
day 21
Title
joint angles
Description
Joint amplitudes measured during gait assessment with the GRAIL
Time Frame
day 51
Title
number of steps per 24h
Description
Number of steps per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Time Frame
day 1
Title
number of steps per 24h
Description
Number of steps per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Time Frame
day 21
Title
number of steps per 24h
Description
Number of steps per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Time Frame
day 51
Title
travelled distance
Description
distance traveled per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Time Frame
day 1
Title
travelled distance
Description
distance traveled per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Time Frame
day 21
Title
travelled distance
Description
distance traveled per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Time Frame
day 51
Title
quality of sleep: wristband actimeter
Description
quality of sleep per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Time Frame
day 1
Title
quality of sleep: wristband actimeter
Description
quality of sleep per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Time Frame
day 21
Title
quality of sleep: wristband actimeter
Description
quality of sleep per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Time Frame
day 51
Title
cardiac frequency
Description
heart rate per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Time Frame
day 1
Title
cardiac frequency
Description
heart rate per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Time Frame
day 21
Title
cardiac frequency
Description
heart rate per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Time Frame
day 51
Title
Evaluation of spasticity
Description
Evaluation of spasticity by the modified Ashworth scale
Time Frame
day 1
Title
Evaluation of spasticity
Description
Evaluation of spasticity by the modified Ashworth scale
Time Frame
day 21
Title
Evaluation of spasticity
Description
Evaluation of spasticity by the modified Ashworth scale
Time Frame
day 51
Title
functional independence
Description
Overall functional independence assessed with the MIF-Môme autonomy scale
Time Frame
day 1
Title
functional independence
Description
Overall functional independence assessed with the MIF-Môme autonomy scale
Time Frame
day 21
Title
functional independence
Description
Overall functional independence assessed with the MIF-Môme autonomy scale
Time Frame
day 51
Title
motor functions
Description
Overall motor function evaluated with the EMFG
Time Frame
day 1
Title
motor functions
Description
Overall motor function evaluated with the EMFG
Time Frame
day 21
Title
motor functions
Description
Overall motor function evaluated with the EMFG
Time Frame
day 51
Title
muscular strength
Description
Muscle strength will be measured with a quotation scale (1 to 5) for manual muscle testing
Time Frame
day 1
Title
muscular strength
Description
Muscle strength will be measured with a quotation scale (1 to 5) for manual muscle testing
Time Frame
day 21
Title
muscular strength
Description
Muscle strength will be measured with a quotation scale (1 to 5) for manual muscle testing
Time Frame
day 51
Title
Body composition measurements
Description
fat body mass
Time Frame
day 21
Title
Body composition measurements
Description
fat body mass
Time Frame
day 51
Title
Body composition measurements
Description
lean body mass
Time Frame
day 21
Title
Body composition measurements
Description
lean body mass
Time Frame
day 51
Title
brain activated areas
Description
Functional brain connectivity analyzes by functional brain MRI
Time Frame
day 21
Title
brain activated areas
Description
Functional brain connectivity analyzes by functional brain MRI
Time Frame
day 51
10. Eligibility
Sex
All
Minimum Age & Unit of Time
4 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Hemiplegic children aged from 4 to 18 years
GMFCS (Gross Motor Function Classification System) score between I and III with lower limb involvement.
Children must walk alone with or without aid at least 10 meters, must have acquired sitting position, must be able to understand simple orders to follow the rehabilitation program.
Free and informed consent of holders of parental authority and of the patient
Affiliated to the social security system
Exclusion Criteria:
No lower limb involvement,
spasticity = 4 on the modified Ashworth scale,
severe cardiorespiratory disease forbidding the rehabilitation program,
orthopedic surgery or botulinic toxin injections in the last 6 months before the beginning of the study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Catherine Sarret
Organizational Affiliation
University Hospital, Clermont-Ferrand
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU Clermont Ferrand
City
Clermont-Ferrand
State/Province
Auvergne
ZIP/Postal Code
63000
Country
France
12. IPD Sharing Statement
Learn more about this trial
Intensive Robotic Rehabilitation in Children With Hemiparesia Using GEOSYSTEM
We'll reach out to this number within 24 hrs